KEY INVESTMENT CONSIDERATIONS – • 5 consecutive years of increased profitability • 7 consecutive years of increased sales • No significant share dilution in over five years • Increasing cash / No debt • Conservative management does not engage in “pump-and-dump” promotional activity • PCYN has been a publicly traded stock since 1996
BUSINESS DESCRIPTION - Procyon Corporation, through its wholly owned subsidiaries, engages in the development and marketing of medical products used in the treatment of wound and skin problems (pressure ulcers, dermatitis, inflammation), and markets diabetic supplies (glucose monitors, heating pads, lancets, test strips, and syringes) primarily to Medicare customers. PCYN sells products through distributors to healthcare institutions (such as physicians, nursing homes, and home healthcare agencies) and to retailers (national and regional chain stores and pharmacies).